Form 497K COLUMBIA FUNDS SERIES
Supplement dated May 18, 2018
to the Prospectus and Summary Prospectus of the following
fund:
| Fund | Prospectus and Summary Prospectus Dated |
| Columbia Funds Series Trust I | |
| Multi-Manager Alternative Strategies Fund | 1/1/2018 |
On March 7, 2018, the Fund's
Board of Trustees approved the addition of AlphaSimplex Group, LLC (AlphaSimplex) to manage a portion of the Fund's assets, effective on or about May 23, 2018 (the Effective Date). Accordingly, on the Effective Date, the following changes are
hereby made to the Fund's prospectus and summary prospectus.
On the Effective Date, the second paragraph under the
subsection “Principal Investment Strategies” in the summary prospectus and the “Summary of the Fund” and “More Information About the Fund” sections of the prospectus is hereby superseded and replaced with the
following:
Columbia Management is responsible for
providing day-to-day portfolio management of a sleeve and is also responsible for oversight of the Subadvisers. The Fund’s Subadvisers are AlphaSimplex Group, LLC (AlphaSimplex), AQR Capital Management, LLC (AQR), Manulife Asset Management
(US) LLC (Manulife), TCW Investment Management Company LLC (TCW) and Water Island Capital, LLC (Water Island). Columbia Management, subject to the oversight of the Fund’s Board of Trustees, determines the allocation of the Fund’s assets
to each sleeve, and may change these allocations at any time. Columbia Management and the Subadvisers act independently of each other and use their own methodologies for selecting investments.
On the Effective Date, the sixth through ninth paragraphs
under the subsection “Principal Investment Strategies” in the summary prospectus and the “Summary of the Fund” and “More Information About the Fund” sections of the prospectus are hereby superseded and
replaced with the following:
It is anticipated that the
Fund will make substantial use of derivatives, including both exchange-traded and over-the-counter (OTC) instruments. The Fund may invest in forward contracts (including forward foreign currency contracts and forward interest rate agreements),
futures (including commodity-linked, currency, equity, index, interest rate, and other bond futures), options (including options on currencies, equities, and interest rates), structured investments (including commodity-linked structured notes),
swaps (including equity swaps, swaps on commodity, equity and fixed income/bond futures, and credit default, cross-currency, interest rate and total return swaps) and options on swaps (commonly known as “swaptions”). The Fund may use
these derivatives in an effort to implement the Fund’s strategy, to produce incremental earnings and enhance total return, to hedge existing positions, to increase market or credit exposure (including using derivatives as a substitute for the
purchase or sale of the underlying security or other asset), to manage certain investment risks and/or as a substitute for the purchase or sale of securities, currencies or commodities, and/or to change the Fund’s effective duration. One or
more of the strategies used by the Fund and the Subsidiaries (as defined below) may result in leveraged exposure in general and to one or more specific asset classes.
The Fund may invest in securities and instruments, including
derivatives, indirectly through two offshore, wholly-owned subsidiaries organized under the laws of the Cayman Islands (together the Subsidiaries, each a Subsidiary), managed by Columbia Management and subadvised by AlphaSimplex and AQR,
respectively. The Subsidiaries have substantially the same investment objective as the Fund and their investments are consistent with the Fund’s investment restrictions applied on a “look through” basis. The Subsidiaries invest
mainly in futures and/or swaps, including, but not limited to, commodity-related futures, swaps and swaps on commodity futures, but they may also make any other investments the Fund may make, including investments intended to serve as margin or
collateral for the Subsidiaries’ derivative positions. Unlike the Fund (which is subject to limitations under U.S. federal tax laws), the Subsidiaries may invest without limitation in commodity-linked derivatives; however, the Fund and its
Subsidiaries will comply on a consolidated basis with asset coverage or segregation requirements. AlphaSimplex and AQR are expected to invest no more than 25% of the total assets of their respective sleeves in the Subsidiaries that they subadvise,
and the Fund, in the aggregate, will not invest more than 25% of its total assets in the Subsidiaries.
The Fund expects to hold a significant amount of cash, U.S.
Treasury securities, money market instruments (which may include investments in one or more affiliated or unaffiliated money market funds or similar vehicles), other high-quality, short-term investments or mortgage-backed securities, or other liquid
assets to meet its segregation obligations as a result of its investments in derivatives.
The Subsidiaries’ commodity-linked investments are
expected to produce leveraged exposure to the performance of the commodities markets. In addition to its investments in commodity-linked derivative instruments, the Fund may, through investments in the Subsidiaries, invest directly in physical
commodities, including but not limited to, gold, silver, platinum and palladium.
On the Effective Date, the information under the subsection
“Fund Management” in the summary prospectus and the “Summary of the Fund” section of the prospectus is hereby revised to add the following:
Subadviser: AlphaSimplex
Group, LLC (AlphaSimplex)
| Portfolio Manager | Title | Role with Fund | Managed Fund Since | |||
| Alexander Healy, Ph.D. | Deputy Chief Investment Officer and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 |
SUP100_08_009_(05/18)
| Portfolio Manager | Title | Role with Fund | Managed Fund Since | |||
| Kathryn Kaminski, Ph.D., CAIA | Chief Research Strategist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Philippe Lüdi, Ph.D., CFA | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| John Perry, Ph.D. | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Robert Rickard | Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Robert Sinnott | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 |
The rest of the section
remains the same.
On the Effective Date, the following
information is added at the end of the section "Principal Investment Strategies" in the "More Information About the Fund" section of the prospectus:
The AlphaSimplex Sleeve — Managed Futures Strategy
Under normal market conditions, AlphaSimplex extensively uses
a variety of derivative instruments, including futures and forward contracts, to capture the exposures suggested by its absolute return strategy while also seeking to add value through volatility management. These market exposures, which are
expected to change over time, may include, for example, exposures to the returns of U.S. and non-U.S. equity and fixed-income securities indices (including both broad- and narrow-based securities indices), currencies and commodities. AlphaSimplex
has great flexibility to allocate derivatives exposure among various securities, indices, currencies, commodities and other instruments; the amount of the sleeve’s assets that may be allocated to derivative strategies and among these various
instruments is expected to vary over time. AlphaSimplex uses proprietary quantitative models to identify price trends in equity, fixed-income, currency and commodity instruments across time periods of various lengths. AlphaSimplex believes that
asset prices may show persistent trending behavior due to a number of behavioral biases among market participants as well as certain risk-management policies that will identify assets to purchase in upward-trending markets and identify assets to
sell in downward-trending markets. AlphaSimplex believes that following trends across a widely diversified set of assets, combined with active risk management, may allow it to earn a positive expected return in its sleeve over time. The sleeve may
have both “short” and “long” exposures within an asset class based upon AlphaSimplex’s analysis of multiple time horizons to identify trends in a particular asset class. AlphaSimplex scales the notional exposure of the
futures and currency forward positions with the objective of targeting a relatively stable level of annualized volatility.
AlphaSimplex’s sleeve may from time to time emphasize
one or more sectors in selecting its investments, including the financial services sector.
Although AlphaSimplex does not intend to invest in physical
commodities directly, it expects to obtain investment exposure to commodities and commodity-related derivatives by investing in its Subsidiary. AlphaSimplex sleeve’s investment returns may be volatile over short periods of time.
On the Effective Date, the information under the subsection
"Primary Service Providers - The Investment Manager" in the "More Information About the Fund" section of the prospectus is revised to add the following to the end of the fifth paragraph:
A discussion regarding the basis for the Board’s
approval of the adoption of the investment subadvisory agreement with AlphaSimplex will be available in the Fund’s annual report to shareholders for the fiscal year ending August 31, 2018.
The date the Subadvisers began serving the Fund is set forth
under Subadvisers below. Any performance of the Fund prior to the date the Subadvisers began serving was achieved by one or more different subadvisers. Similarly, the portfolio turnover rate for periods prior
to the Subadvisers’ management of the Fund was the result of management by one or more different subadvisers. A change in subadvisers may result in increased portfolio turnover.
The rest of the section remains the same.
On the Effective Date, the information under the subsection
"Primary Service Providers - Subadvisers" in the "More Information about the Fund" section of the prospectus is hereby revised to add the following:
Subadviser: AlphaSimplex
Group, LLC (AlphaSimplex)
AlphaSimplex, which has
served as Subadviser to the Fund and its Subsidiary since May 2018, is located at 255 Main Street, Cambridge, Massachusetts 02142. AlphaSimplex, subject to the supervision of Columbia Management, provides day-to-day management of a portion of
the Fund’s portfolio, as well as investment research and statistical information, under a Subadvisory Agreement with Columbia Management. AlphaSimplex has been a registered investment adviser with the SEC since 2003. AlphaSimplex was organized
as a Delaware limited liability company in 1999 and specializes in providing quantitative advisory and subadvisory services.
| Portfolio Manager | Title | Role with Fund | Managed Fund Since | |||
| Alexander Healy, Ph.D. | Deputy Chief Investment Officer and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Kathryn Kaminski, Ph.D., CAIA | Chief Research Strategist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 |
2
SUP100_08_009_(05/18)
| Portfolio Manager | Title | Role with Fund | Managed Fund Since | |||
| Philippe Lüdi, Ph.D., CFA | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| John Perry, Ph.D. | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Robert Rickard | Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 | |||
| Robert Sinnott | Senior Research Scientist and Portfolio Manager of AlphaSimplex | Co-Portfolio Manager | May 2018 |
Alexander Healy, Ph.D. joined AlphaSimplex in 2007 and currently serves as Deputy Chief Investment Officer, focusing on risk management, asset allocation, and non-parametric investment models. Dr. Healy received an A.B. in Mathematics and
Computer Science in 2002 and a Ph.D. in Theoretical Computer Science in 2007, both from Harvard University.
Kathryn Kaminski, Ph.D., CAIA
joined AlphaSimplex in 2018 and currently serves as Chief Research Strategist and Portfolio Manager, focusing on portfolio construction and risk management. Prior to joining AlphaSimplex, Dr. Kaminski was a visiting scientist at the MIT Laboratory
for Financial Engineering and held portfolio management positions as a director, investment strategies at Campbell and Company and as a senior investment analyst at RPM, a CTA fund of funds. Dr. Kaminski received her B.S. in Electrical Engineering
and Ph.D. in Operations Research from Massachusetts Institute of Technology.
Philippe Lüdi, Ph.D., CFA
joined AlphaSimplex in 2006 and currently serves as Senior Research Scientist, focusing on product and system engineering. Dr. Lüdi received the equivalent of an M.A. in Molecular and Computational Biology from the University of Basel in 2000,
followed by an M.S. in Statistics in 2002 and a Ph.D. in Bioinformatics in 2006, both from Duke University.
John Perry, Ph.D. joined
AlphaSimplex in 2012 and currently serves as Senior Research Scientist, focusing on research and portfolio management. Dr. Perry received a B.S. in Computer Engineering from the University of Utah and an M.S. in Management and a Ph.D. in Electrical
Engineering and Computer Science from Massachusetts Institute of Technology.
Robert Rickard joined
AlphaSimplex in 2015 and currently holds the position of Portfolio Manager. Mr. Rickard focuses on the management of short-term assets with AlphaSimplex’s products. Prior to joining AlphaSimplex, Mr. Rickard was at Reich & Tang. Mr.
Rickard holds an M.B.A. in Finance from Pace University and a B.S. in Accounting from Siena College.
Robert Sinnott joined
AlphaSimplex in 2009 and currently serves as Senior Research Scientist for trend and relative-value models. Mr. Sinnott received both an A.B. and A.M. in Statistics from Harvard University.
The rest of the section remains the same.
Shareholders should retain this Supplement for future
reference.
3
SUP100_08_009_(05/18)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at E
- Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
- OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share